Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension (vol 71, pg 1601, 2018)

被引：0

|

作者：

Phillips, R. A.

Xu, J.

Peterson, L. E.

Arnold, R. M.

Diamond, J. A.

Schussheim, A. E.

机构：

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 19期

关键词：

D O I：

10.1016/j.jacc.2018.04.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：2280 / 2280

页数：1

相关论文

共 50 条

[31] A risk-benefit assessment of mirtazapine in the treatment of depression (vol 17, pg 251, 1997)
Kasper, S
Praschak-Rieder, N
Tauscher, J
Wolf, R
DRUG SAFETY, 1998, 18 (02) : 123 - 123
[32] Left Ventricle Replacement Fibrosis Detected by CMR Associated With Cardiovascular Events in Systemic Sclerosis Patients (vol 71, pg 703, 2018)
Mousseaux, E.
Agoston-Coldea, L.
Marjanovic, Z.
Stanciu, R.
Deligny, C.
Perdrix, L.
Boutouyrie, P.
Azarine, A.
Soulat, G.
Farge, D.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (25) : 2988 - 2988
[33] Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials (vol 14, e1002410, 2017)
Basu, Sanjay
Sussman, Jeremy B.
Rigdon, Joseph
Steimle, Lauren
Denton, Brian T.
Hayward, Rodney A.
PLOS MEDICINE, 2021, 18 (09)
[34] Evidence-based evaluation of calcium channel blockers for hypertension: Equality of mortality and cardiovascular risk relative to conventional therapy (vol 39, pg 315, 2002)
Opie, LH
Schall, R
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (08) : 1409 - 1410
[35] Patients Prefer Pictures to Numbers to Express Cardiovascular Benefit From Treatment (vol 6, pg 196, 2008)
Spiegelhalter, D. J.
ANNALS OF FAMILY MEDICINE, 2008, 6 (04) : 372 - 372
[36] Rural and Urban Characteristics Impact Cardiovascular Risk Reduction (vol 30, pg 299, 2010)
McConnell, Timothy R.
Santamore, William P.
Larson, Sharon L.
Homko, Carol J.
Kashem, Mohamed
Cross, Robert C.
Bove, Alfred A.
JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2010, 30 (06) : 373 - 373
[37] Hypertension: The most important non communicable disease risk factor in India (vol 70, pg 565, 2018)
Gupta, Rajeev
Xavier, Denis
INDIAN HEART JOURNAL, 2021, 73 (01) : 139 - 139
[38] Updated New Zealand cardiovascular disease risk-benefit prediction guide (vol 321, pg 709, 2000)
Jackson, R
BRITISH MEDICAL JOURNAL, 2000, 321 (7274): : 1454 - 1454
[39] Disease impact number and population impact number: population perspectives to measures of risk and benefit (vol 321, pg 950, 2000)
Heller, RF
Dobson, AJ
BRITISH MEDICAL JOURNAL, 2000, 321 (7274): : 1454 - 1454
[40] Uric acid as independent risk factor in the treatment of hypertension (vol 352, pg 670, 1998)
Ward, HJ
LANCET, 1998, 352 (9131): : 912 - 912

← 1 2 3 4 5 →